Acetyl-L-Carnitine | Prediabetes Supplements Research

acetyl-l-carnitine diabetes diet supplement and metabolic syndrome managementAcetyl-L-Carnitine supplement science abstracts related to diabetes and pre-diabetes metabolic syndrome.

Click the link or go to PubMed and copy the title in the search field.

L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function.

Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Noninvasive assessment of exercise-related intramyocellular acetylcarnitine in euglycemia and hyperglycemia in patients with type 1 diabetes using ¹H magnetic resonance spectroscopy: a randomized single-blind crossover study.

Oral acetyl-L-carnitine therapy and insulin resistance.

Acetyl-L-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy.

The neuropathy-protective agent acetyl-L-carnitine activates protein kinase C-gamma and MAPKs in a rat model of neuropathic pain.

Role of acetyl-L-carnitine in the treatment of diabetic peripheral neuropathy.

Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor.

The heterogeneity of diabetic neuropathy.

Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.

Acetyl-L-carnitine in neuropathic pain: experimental data.

Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies.

Counteraction on experimentally induced diabetic neuropathy by levocarnitine acetyl.

Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine.

Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study.

Share Button